| Systematic (IUPAC) name | |
|---|---|
| Methyl (1R,2R,4S)-4-[(2R,5S,6S)-4-dimethylamino-5-[(2S,4S,5S,6S)-4-hydroxy-6-methyl | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | IV |
| Identifiers | |
| CAS number | 57576-44-0 |
| ATC code | L01DB04 |
| PubChem | CID 42474 |
| ChemSpider | 1931 |
| UNII | 74KXF8I502 |
| KEGG | D02756 |
| ChEMBL | CHEMBL1697719 |
| Chemical data | |
| Formula | C42H53NO15 |
| Mol. mass | 811.86 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Aclarubicin (INN) or Aclacinomycin A[1] is an anthracycline drug[2] that is used in the treatment of cancer. Soil bacteria Streptomyces galilaeus can produce aclarubicin.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)